A hidden atrial dysfunction may raise stroke risk in people with transthyretin amyloid cardiomyopathy (ATTR-CM); however, a ...

Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Tenosynovial tissue sampling at the time of carpal tunnel ...

Novel directed therapies for transthyretin cardiac amyloidosis (ATTR) have been shown to improve outcomes and reduce the long-term negative effects of unchecked amyloid proliferation in patients with ...

MUNICH — Treatment with tafamidis (Vyndaqel, Pfizer) was associated with a reduction in all-cause mortality, as well as cardiovascular hospitalizations, and functional decline vs placebo in a new ...

A type of heart failure caused by a build-up of amyloid can be accurately diagnosed and prognosticated with an imaging technique, eliminating the need for a biopsy, according to a multicenter study ...

Amyloid heart disease is under-recognized. Early detection and prompt initiation of therapy are critically important. With advances in imaging technology, the diagnosis or surveillance of cardiac ...

The type of ATTR you have and how early it was diagnosed are two factors that can affect the prognosis of your disease.

The heart-focused artificial intelligence company Anumana is looking to break new ground for its algorithms through a partnership with Pfizer. They plan to develop programs that can help diagnose ...

Healio spoke with Joban Vaishnav, MD, director of the Johns Hopkins Comprehensive Amyloidosis Center, about the process of diagnosing amyloidosis, the importance of multidisciplinary care in patients ...

Cardiac amyloidosis is underrecognized in patients with heart failure; however, recent improvements in the understanding of this disease have led to developments in diagnosis and treatment. Cardiac ...